Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment

Hanhua Ji1, Yang Li2, Zeyuan Fan2

  • 1Department of Cardiology, Civil Aviation General Hospital, Civil Aviation Clinical Medical College of Peking University, No.1, Gaojingjia, Chaoyang District, Beijing, 100100, China. hanhuaji@foxmail.com.

Insights

The monocyte to lymphocyte ratio (MLR) predicts coronary artery disease (CAD) presence and lesion severity. MLR demonstrates superior performance over neutrophil to lymphocyte ratio (NLR) in assessing coronary lesion severity.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Coronary artery disease (CAD) poses a significant global health challenge.
  • Identifying reliable biomarkers for CAD severity is crucial for patient management.
  • The monocyte to lymphocyte ratio (MLR) is an emerging hematological parameter.

Purpose of the Study:

  • To investigate the predictive value of MLR for lesion severity in CAD patients.
  • To determine if MLR is an independent risk factor for CAD.
  • To compare the efficacy of MLR with neutrophil to lymphocyte ratio (NLR) in reflecting coronary lesion severity.

Main Methods:

  • Retrospective analysis of 543 patients undergoing coronary angiography.
  • Calculation of MLR from routine blood examination (monocytes/lymphocytes).
  • Multivariate logistic and ordinal logistic regression analyses to assess risk factors and lesion severity correlation.
  • Receiver-operating characteristic (ROC) curve analysis for optimal cut-off determination.

Main Results:

  • MLR is an independent risk factor for CAD presence (OR: 3.94) and a predictor of lesion severity (OR: 2.05).
  • MLR showed a positive correlation with Syntax score (r=0.437, p<0.001).
  • Optimal MLR cut-off of 0.25 predicted severe coronary lesions with 60.26% sensitivity and 78.49% specificity.

Conclusions:

  • MLR is a valuable independent risk factor for CAD and a predictor of its lesion severity.
  • MLR exhibits superior performance compared to NLR in reflecting the severity of coronary lesions.
  • MLR can serve as a useful, readily available biomarker in the clinical assessment of CAD.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...